INTRODUCTION 43
Tauopathies are neurodegenerative diseases characterized accumulation of tau protein 44 in ordered assemblies . Tauopathy progresses according to predictable patterns in 45 patients(1) and has been proposed to involve brain networks (2, 3) . Our initial studies 46 described the diversity of self-propagating fibrillar conformations in vitro(4), and the 47 ability of tau aggregates to propagate pathology from the outside to the inside of a cell, 48 and between cells(5). Concurrent work from the Tolnay group demonstrated that 49 inoculation of mouse brain with tau aggregates induced local pathology in a transgenic 50 mouse model (6) . This led us initially to propose that tau had properties similar to the 51 prion protein, PrP (7) . In subsequent work, we propagated distinct tau strains in cultured 52 cells that we used to create transmissible tauopathy in mouse models, with faithful, 53 inter-animal propagation of defined pathology (7) . This was the first evidence that an 54 infectious form of tau created in vitro, would faithfully transmit unique conformations 55 between animals, and we henceforth referred to tau as a prion. This idea remains 56 controversial (8, 9) . Nonetheless, similar results from multiple groups (10-12) and the 57 effectiveness of immunotherapies against tau in mouse models(13) have now led to a 58 general recognition of the idea that transcellular propagation of pathology could underlie 59 pathogenesis of tauopathies and other amyloidoses. The precise mechanisms are 60 unknown.
MATERIALS AND METHODS

77
Generation of CRISPR/Cas9 knockout cells and lentiviral transduction 78 Two human gRNA sequences per gene were selected from the optimized GeCKO 79 version 2(26) or Brunello libraries (27) . DNA oligonucleotides were synthesized (IDT), 80 and cloned into the lentiCRISPR v2 vector (26) for lentivirus production. Lentivirus was 81 created as described previously (28). For transduction, a 1:30 dilution of virus 82 suspension was added to the cells. After 24h infected cells were treated with 1μg/ml 83 puromycin (Life Technologies) and cultured for 2 days, followed by passaging 1:5 and a 84 second round of virus and puromycin application. The cells were cultured at least 10 85 days after the first lentiviral transduction before using them for experiments. then 30X (15s at 95°C, 15s at 60°C, 1min at 72°C) and 10 min at 72°C. The PCR 97 product was run on a 1% agarose gel to verify the product size and gel-extracted using 98 the QIAquick gel extraction kit (Qiagen). Purified PCR samples were Sanger 99 sequenced at the sequencing core facility at UT Southwestern Medical Center.
100
Sequencing files were used for TIDE. Analysis was performed according to the 101 software instructions. The presence of aberrant sequence signal, R 2 value and the 102 knockout efficiency were considered to evaluate the results(22). One gRNA was 103 selected for each gene based on its gene knockout efficacy (Table 1) .
105
Uptake assay 106 HEK293T cells were plated at 15000 cells per well in a 96-well plate. Fluorescently 107 labeled tau aggregates were sonicated (QSonica) for 30s at a setting of 65 108 (corresponding to ∼80 watts) and were applied to cell media for 4h as per prior studies 48h cells were harvested with 0.05% trypsin, fixed in 2% paraformaldehyde for 10 min 129 and then resuspended in flow cytometry buffer (HBSS plus 1% FBS and 1 mM EDTA). 130 We quantified FRET as described previously using the LSRFortessa (29) propagate aggregates that enable detection by FRET, as distinct from the first 142 description of the tau RD(P301L/V337M)-YFP cells described previously (7, 20) . LM 39-9 143 cells were plated at 10000 cells per well in a 96-well plate. After transduction with virus 144 encoding appropriate gRNA, cells were maintained for 2 weeks prior to analysis. Cells 145 were harvested with 0.05% trypsin and fixed in 2% paraformaldehyde for 10min, and 146 then resuspended in flow cytometry buffer (HBSS plus 1% FBS and 1 mM EDTA). The
147
LSRFortessa SORP (BD Biosciences) was used to perform FRET flow cytometry. FRET 148 was quantified as described previously (23) We first identified the candidate genes based on the reported GWAS of AD (14). Meta-160 analysis of different GWAS has confirmed the importance of 22 genes as AD risk 161 modifiers (Table 1) (16). We targeted each gene individually with two independent guide 162 RNAs (gRNAs). The gRNAs were cloned into a lentivirus construct (21), and transduced 163 into cultured cells. Cells were cultured for 10 days in the presence of puromycin to 164 select for stable integration of the virus and presumed genetic disruption. We confirmed 165 genetic disruption of each gene using Tracking of Indel by DEcomposition (TIDE), a 166 method based on sequencing the target genes to detect disruption of the sequence 167 through insertion/deletion (indel) at the site of gRNA binding (22). This confirmed high 168 frequency indels at each of the genes targeted by our constructs (see Table 1 ;
169 Supplementary data- Fig S1 for an example) . We selected the gRNAs with high indel 170 efficiency (>80%) in TIDE analysis (Table 1) and used those gRNAs for subsequent 171 assays. We noted that 6 genes are reportedly expressed at very low or undetectable 172 levels in HEK293 cells (Table 1) , but carried these through in our analyses nonetheless. AD GWAS gene disruption does not affect tau uptake 181 We have previously determined that heparan sulfate proteoglycans (HSPGs) play a 182 critical role in binding tau aggregates, mediating their uptake and seeding activity (17), 183 (18). Compounds such as heparin or similar small molecules, which bind tau 184 assemblies and compete for their binding to HSPGs, block tau uptake (18). We tested 185 the role of GWAS genes by evaluating HEK293T cells in which we had individually 186 disrupted each. As a positive control, we knocked out NDST1, which we have 187 previously determined to be required for proper HSPG sulfation and to mediate tau 188 uptake (18). We prepared full-length (2N4R) fibrils and labeled them using Alexa Fluor 189 647 via succinimidyl ester amine reaction. We applied labeled tau fibrils to cultured cells 190 for 4h, followed by washing, trypsin treatment (to digest extracellular tau and release 191 cells from the culture plate), and analysis by flow cytometry according to prior methods 192 (17). We observed no effect of GWAS gene knockout on tau uptake, whereas heparin 193 treatment reduced uptake approximately 90%, and NDST1 knockdown reduced uptake 194 approximately 50% (Fig. 1) . As an alternative, incubation of tau seeds with Lipofectamine (or a similar reagent) 220 enables transduction of seeds with very high efficiency, approximately 100-fold more 221 than naked seeding. We expressed tau RD(P301S)-C/R in HEK293 cells to form a 222 monoclonal "biosensor" line with high sensitivity to exogenous tau aggregates, similar to 223 a line previously reported (23). To test the role of GWAS genes in the tau seeding 224 process, we knocked out each in the biosensor cells. These were treated with 7 225 exogenous tau fibrils alone, or with Lipofectamine(19). We measured seeding activity by 226 quantitative flow cytometry. We observed no consistent significant effect of GWAS 227 gene knockout upon naked seeding (Fig. 2) or after Lipofectamine-mediated aggregate 228 delivery (Fig. 3) . GWAS gene disruption does not affect tau aggregate maintenance 252 We have previously observed that dividing cells propagate tau aggregates of distinct 253 conformation, termed strains, that transmit pathology between animals, and specify 254 unique pathologies (7, 20) . Studies of yeast prions indicate that aggregate propagation 255 requires accessory factors, e.g. Hsp104(24), and thus we hypothesized AD GWAS 256 genes might affect this process. We created a cell line that propagated a distinct tau 257 strain, termed LM39-9. These cells constitutively express aggregates of tau RD cytometry. We used lentivirus to individually disrupt each of the AD GWAS genes, 262 cultured the LM39-9 cells for 2 weeks, and then quantified the percentage of cells 263 containing aggregates using flow cytometry. We observed no loss of aggregation 264 following disruption of any GWAS gene (Fig. 4) , indicating none was critical to 265 aggregate maintenance in this cell model. this work we tested the hypothesis that AD GWAS genes would impact uptake, seeding, 280 or aggregate maintenance of tau, which may play a critical role in neurodegeneration.
281
We confirmed each of the 22 gRNAs we studied in fact disrupted their target genes at 282 high frequency. We then studied the effects of the knockouts across a range of putative 283 steps in pathogenesis for which we have previously developed quantitative cell-based 284 assays. We did not observe any impact on knockout in any of the fundamental events of 285 tau aggregate propagation that we can measure in simple cell systems. are reportedly not expressed at high levels in these cells, and thus cannot be 295 completely excluded as important for tau prion propagation (although they are clearly 296 not required for this process to occur in HEK293T cells).
298
Due to the impracticality of optimizing detection methods to measure expression levels 299 of multiple proteins, we confirmed the function of our knockout vectors with sequencing 300 of endogenous genes. Future studies in neurons, which present additional challenges to 301 screening studies we have performed here, would be helpful in this regard. However the 302 HEK293T models have previously proven very useful in defining modes of cell uptake of 303 pathological tau assemblies, seeding, and strain maintenance that have translated well 304 to primary neurons and mouse models (7, 17, 18) . Similarly, these simple systems have 305 readily propagated unique tau strains derived from recombinant fibrils and human 306 tauopathy brains that can be transmitted and propagated in animal models (7, 25) . We 307 fully recognize that without extension of findings derived from simple systems such as 308 these into animal or even human studies it will be difficult to know how these simple 309 models reflect actual events in the brain.
311
The relationship of GWAS to AD pathogenesis is complex, as hits may involve genes 312 that are not directly involved in the hypothetically critical process of tau propagation. For 313 example, genes associated with microglial function, such as TREM2, would not be 314 expected to score positive in these studies. Nonetheless, we hope our work will serve 315 as an important reference for those interested in using reductionist cell models to study 316 the role of genes involved in fundamental events of tau propagation. 9 317 318
